Significant Ownership of InnoCare Pharma Inc.

Signature - Title: /s/ Jisong Cui - By Jisong Cui, Chairperson and CEO
Location: Princeton, NJ
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by InnoCare Pharma Inc..

Notify me when InnoCare Pharma Inc. files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ZBIO	Zenas BioPharma, Inc.	Common Stock, par value $0.0001 per share	9.4%	$111,026,500		5,000,000		InnoCare Pharma Inc.	07 Oct 2025

Schedules 13D/G Reported by InnoCare Pharma Inc.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.